地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771149750
传真:18771149750
邮箱:sales@amyjet.com

List Labs公司成立于1978年,位于美国加州硅谷,是一家专业提供各类微生物Toxin的生物技术公司。
Our company was founded in 1978 by Linda Shoer. Cholera toxin, the first product, was sought after by those doing research in signal transduction and by others using the toxin B subunit to label neurons. At that time there were no commercial suppliers of this toxin. Our company has always focused on quality bacterial toxins, which you can depend on for your research. Because toxins have been the basis for many vaccines, List Labs products have supported vaccine development. List Labs was the first to commercialize many bacterial toxins for research, including C.difficile toxins and pertussis toxin. Today, we remain uniquely focused on manufacturing, offering and supporting a wide range of bacterial products.
List Labs' heart is in the science and the discovery of innovative reagents. Our office is located in Campbell, California, in Silicon Valley. We serve the global research community with an expanding group of distributors. Years of experience translate into expertise in the production, shipment and handling of dangerous goods. If you have questions about any of our products or services, contact us.
List Biological Labs的主要产品包括:
Anthrax Toxins
Antisera & Antibodies
Botulinum Toxins
Cholera Toxins
Difficile Toxins
Diphtheria Toxin & Crm
Exotoxin A
Fret Peptides, Native Substrates & Receptors
Lipopolysaccharides
Pertussis Toxins & Virulence Factors
Shiga Toxins
Staphylococcal Toxins
Tetanus Toxins & Related Products
Toxoids
Vaccine Carrier Proteins And Adjuvants
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="List Labs"> List Labs
艾美捷科技有限公司代理Mimotopes公司多肽及多肽合成相关产品。Mimotopes公司位于澳大利亚,可以提供2000余种多肽,100余种药物及化妆品肽,1000余种各类氨基酸及多肽合成用试剂。
Mimotopes公司的主要产品类别:
(1)多肽(Peptides)
库存普通多肽(Catalogue Peptides)
化妆品肽(Cosmetic Peptides)
药物肽(Pharmaceutical Peptides)
肽库(Off-the-Shelf Library)
(2)氨基酸(Amino Acids)
Z Amino Acids
Unusual Amino Acids
N methyl Amino Acids
Fmoc Amino Acids
Common Amino Acids
Boc amino acids
AA attached_to_2-Chlorotrityl_Resin
AA attached_to_Wang_Resin
(3)多肽合成试剂(Peptides Synthesis Reagents)
Coupling Reagents
Amino Alcohols
General Reagents
Linkers
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Mimotopes"> Mimotopes艾美捷科技有限公司代理Kingfisher Biotech公司产品,详见:
http://www.amyjet.com/Index/lists/catid/27/kid/51.html
Kingfisher Biotech致力于兽医学研究和人类疾病的动物模型,涵盖的物种包括:牛、狗、马、鸡、海豚、猫、猪、仓鼠、小鼠、兔子、大鼠、火鸡等等。目前,Kingfisher Biotech的产品线中有查过1200种重组蛋白、多抗、单抗和ELISA试剂盒,能够为全世界动物保健和动物模型客户提供优质的产品。
Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors.
Kingfisher Biotech公司产品涉及的物种包括:
Bovine、Canine、Caprine、Catfish、Chicken、Dolphin、Equine、Feline、Ferret、Guinea Pig、Hamster、Human、Llama、Monkey、Mouse、Ovine、Rabbit、Rat、Salmon、Swine、Turkey、Zebrafish
| 产品列表 |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1675A-025) |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1675A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1676A-100) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1676A-025) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1676A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1676A-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| Cynomolgus Monkey CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1692Y-003) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1644AP-025) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1644AP-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 alpha (IL-1F1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0667B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Human APRIL (TNFSF13) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0292H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1085H-100) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1085H-025) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1085H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1085H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human CCL21 (6Ckine) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1512H-005) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1531H-025) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1531H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1657GP-100) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1657GP-025) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1657GP-005) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1657GP-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0754D-100) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0754D-025) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0754D-005) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0754D-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0085D-100) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0085D-025) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0085D-005) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0085D-500) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0920D-100) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0920D-025) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0920D-005) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0920D-500) |
| Canine IL-25 (IL-17E) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1697D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Catfish IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0439CF-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Llama ACT1 Activation Monoclonal Antibody (clone LH9A) (Kingfisher, CAT#WS0813L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LH7A) (Kingfisher, CAT#WS0812L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LT78A) (Kingfisher, CAT#WS0823L-100) |
| Llama CD2 or CD6 predicted Monoclonal Antibody (clone LH43A) (Kingfisher, CAT#WS0815L-100) |
| Llama CD2 or CD6 Predicted Monoclonal Antibody (clone LT10A) (Kingfisher, CAT#WS0819L-100) |
| Llama CD44 Monoclonal Antibody (clone LT36A) (Kingfisher, CAT#WS0821L-100) |
| Llama CD45 Predicted Monoclonal Antibody (clone LT12A) (Kingfisher, CAT#WS0820L-100) |
| Llama CD5 Predicted Monoclonal Antibody (clone LT3A) (Kingfisher, CAT#WS0817L-100) |
| Llama CD8 Monoclonal Antibody (clone LT5A) (Kingfisher, CAT#WS0818L-100) |
| Llama MHC II Monoclonal Antibody (clone LT1A) (Kingfisher, CAT#WS0816L-100) |
| Llama Pan B cell Monoclonal Antibody (clone LH41A) (Kingfisher, CAT#WS0814L-100) |
| Llama Pan T cell Monoclonal Antibody (clone LT97A) (Kingfisher, CAT#WS0824L-100) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1031Y-100) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1031Y-025) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1031Y-005) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1031Y-500) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1321Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1321Y-025) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1321Y-005) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1321Y-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody (Kingfisher, CAT#KP1669Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1670Y-050) |
| Cynomolgus Monkey IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1671Y-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody (Kingfisher, CAT#KP1694D-100) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1695D-050) |
| Canine BAFF (TNFSF13B) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1696D-003) |
| Canine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0891D-003) |
| Canine Fas Ligand (FasL) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1288D-003) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1647CT-100) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1647CT-025) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1647CT-005) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1647CT-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0665B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Bovine TNF alpha (TNFSF2) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0675B-003) |
| Bovine VEGF-A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0676B-003) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL2 (MCP-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0659B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0003E-100) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0003E-025) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0003E-005) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0003E-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Zebra Finch SCF (Stem Cell Factor) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1579ZN-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0013B-100) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0013B-025) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0013B-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0013B-500) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0311B-100) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0311B-025) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0311B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0311B-500) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

KAMIYA公司旨在为生命科学和医疗机构提供高品质的创新的实验室研究和诊断工具。KAMIYA公司最早研发的产品是最前沿的用于信号转导研究的蛋白激酶抑制剂staurosporine(星形孢菌素)和K252a。1990年,KAMIYA成为美国第一家生产细胞凋亡研究的anti-Fas单克隆抗体的公司。如今,KAMIYA的产品线包括数千种人和动物临床前试验的生物标志物检测试试剂盒。此外,KAMIYA公司还为生命科学领域的研究着提供多种多样的酶抑制剂、单克隆抗体和多克隆抗体等产品,可用于研究细胞凋亡、耐药性、氧化、DNA损伤和修复、骨骼生物学、癌症、心脏病、炎症、肥胖症、糖尿病等研究。
KAMIYA公司K-ASSAY产品,用于胰岛素、血浆D-二聚体、凝血因子xiii、血浆FDP、血清/尿液 FPD、血清/尿液FDP-E、总IgE等指标的检测。KAMIYA现已发展成美国最大的脂质血清蛋白免疫分析试剂生厂商,为众多大型医院、医疗中心、临床实验室、临床参考实验室、科研机构、诊断试剂研发公司等机构提供优质的临床诊断试剂。
KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Kamiya Biomedical"> Kamiya Biomedical
艾美捷科技特约代理Biogems产品。
BioGems意为生物钻石,其产品涵盖多种荧光标记的流式抗体、具有生物活性的功能性抗体,以及流式细胞术辅助试剂,如溶血剂和破膜剂等。BioGems产品全部在美国生产,目前已拥有超过500种流式试剂和600余种重组蛋白产品。
Through the establishment of joint collaborations with reputable manufacturers of top-quality life-science research products such as PeproTech Inc., BioGems has positioned itself to become a highly competitive source for a wide-range of recombinant protein and flow-cytometry reagents. Currently, our catalog contains more than 600 recombinant proteins and over 500 flow cytometry reagents. To keep up with the rapidly advancing research fronts, BioGems continuously adds new products to its catalog. All of our products are subjected to a thorough and rigorous quality and performance testing to ensure that each and every product meets the highest established standards. Providing our customers with the highest-quality products at affordable prices is our goal. We are confident that the unique business arrangements of BioGems together with our highly skilled and experienced personnel will enable us to achieve this goal.
主要产品分类:
(1)Flow Cytometry
Conjugated Antibodies
SAFIRE Functional Antibodies
Isotype Controls
Custom and Bulk Reagents
Purified Antibodies
Buffers and Solutions
(2)Recombinant Proteins
Growth Factors & Cytokines
Animal-Free Cytokines
Chemokines
Neurotrophins
Other Proteins
Anti Cytokine & Chemokine Antibodies
(3)Small Molecules
Receptor Antagonist and Inhibitors
Receptor Agonists and Activators
(4)Pre-Coated Elisa Kits
Human
Mouse
Rat
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BioGems"> BioGems
VWR作为全球领先的科学技术服务供应商,长期致力于在制药、生物技术、工业、教育、政府和医疗保健领域为实验室和量产客户提供优质产品、服务和解决方案。VWR has long been the leading global, independent provider of product and service solutions to laboratory and production customers, enabling science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries.
VWR的主要产品包括:
VWR Equipment and Instrumentation
All You Need for Analytical Chemistry
Centrifugation
Chemicals
Chromatography (R&D)
Cold Storage
Electrochemistry
Life Science
Liquid Handling
Microscopy
Ovens & Incubators
Organic Synthesis at VWR
Safety
Spectrophotometers
Temperature Measurement & Thermometers
Titration
Weighing
R&D Literature
Beckman Coulter
ELGA
Heidolph
Kimble
METTLER TOLEDO
Molecular Devices
Pall Laboratory
Panasonic Healthcare Corporation of North America
WHEATON
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="VWR"> VWR
INDOOR Biotechnologies公司专注于室内空气品质、环境科学、过敏和哮喘相关的检测用产品和服务。
Indoor Biotechnologies was founded by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology and has served as a consultant to the U.S. National Institutes of Health, the Environmental Protection Agency, academic institutions and Fortune 500 companies..
INDOOR Biotechnologies公司的主要产品包括:
Multiplex IgE-QBA™ Kits
MARIA® Kits
ELISA Kits
Purified Allergens
Molecular Reference Standards
Antibodies
Rhinovirus Products
Allergen Standards
RhinixPRO Nasal Filters
Rapid Test and Dust Collection
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="INDOOR Biotechnologies"> INDOOR Biotechnologies
Swant专注于钙结合蛋白相关产品的研发和销售,产品包括:钙结合蛋白抗体、纯化的重组蛋白、钙离子通道和钙泵抗体以及其他抗体和ELISA。
Antibodies to Calbindin D-28k, Calretinin, Parvalbumin, Calmodulin and to Na2+-Ca2+-exchangers, Ca2+ pumps, neurotransmitters, as well as their respective antigens. Superb staining of subpopulation of neurons or glial cells in various species, including humans. Selective staining of various types of cancers. Our mono- and polyclonal antibodies are of high titer and of high specificity. They can be used in immunohistochemistry and immunoblots at dilution of more than 1:5'000 (Avidin-Biotin-Method). The recombinant antigens have been purified by HPLC and FPLC. The products are supplied in lyophilized form and are accompanied by detailed product description as well as by a method sheet.
Swant 的主要产品包括:
(1)Antibodies against Ca2+ - binding proteins
Calbindin
Calretinin
Parvalbumin
Others
(2)Purified and recombinant proteins
Calbindin
Calretinin
Parvalbumin
Others
(3)Antibodies against Ca2+ exchangers and Ca2+ pumps
Ca2+ - exchangers
Ca2+ - pumps
(4)Various
Antibodies against insulin-like growth factors
Antibodies against neurotransmitters
Antibodies against components of the renin-angiotensin system
Miscellaneous antibodies
(5)ELISA KITS
Sandwich-ELISA
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Swant"> Swant
Calbiotech是为世界各地的大学和研究中心定制开发和制造免疫产品的主要参考实验室,产品包括ELISA、超灵敏的化学发光试剂,IVD RIA和PCR试剂盒。
Calbiotech specializes in immunoassay development and manufacturing, with a comprehensive range of ELISA and CLIA assays for human and animal research, including specific assays for hormone, autoimmune disorders, cancer, infectious diseases and much more. The company has over 200 products which are distributed to over 80 countries globally.
Calbiotech is a key partner for biotech, pharma and CROs, providing contract manufacturing and assay development services, including custom coated microplates, reagents, buffers and other assay components.
Calbiotech的主要产品包括:
(1)ELISA KITS
Products For Research
Products For Export
(2)DEVELOPMENT REAGENTS
Coated Plates
Coating & Blocking Buffers
Stabilizers & Substrates
Sample Prep & Assay Optimization
Commons: Wash, Stop, TMB, PBS
(3)CHEMILUMINESCENT
SAV Coated Magnetic Beads
Chemiluminescent Immunoassays
" data-original="http://hycult.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Calbiotech"> Calbiotech地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:15172431432
邮箱:sales@amyjet.com
0.4195